Whittier Trust Co. of Nevada Inc. Has $1.06 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Whittier Trust Co. of Nevada Inc. lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 74.7% in the second quarter, Holdings Channel.com reports. The fund owned 17,926 shares of the pharmacy operator’s stock after selling 52,928 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in CVS Health were worth $1,059,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in CVS Health by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 117,696,285 shares of the pharmacy operator’s stock worth $9,293,299,000 after acquiring an additional 533,659 shares during the period. Capital World Investors grew its holdings in CVS Health by 8.0% during the 1st quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock worth $3,491,643,000 after acquiring an additional 3,232,172 shares during the period. Capital International Investors grew its holdings in shares of CVS Health by 12.5% in the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock valued at $3,024,334,000 after buying an additional 4,226,225 shares during the period. Norges Bank acquired a new position in shares of CVS Health in the 4th quarter valued at $1,092,040,000. Finally, Capital Research Global Investors grew its holdings in shares of CVS Health by 1.4% in the 1st quarter. Capital Research Global Investors now owns 13,143,822 shares of the pharmacy operator’s stock valued at $1,048,351,000 after buying an additional 184,297 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CVS shares. JPMorgan Chase & Co. decreased their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Baird R W raised shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Wells Fargo & Company boosted their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Bank of America decreased their price target on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Monday, August 19th. Eleven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $73.24.

CVS Health Trading Down 0.5 %

Shares of NYSE:CVS opened at $56.96 on Friday. The company’s 50-day moving average price is $58.67 and its two-hundred day moving average price is $64.71. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The stock has a market capitalization of $71.51 billion, a PE ratio of 10.01, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.21 EPS. On average, equities analysts forecast that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.67%. CVS Health’s dividend payout ratio is presently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.